发明名称 COMBINED HYPOTENSIVE DRUG
摘要 FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to medicine, namely to combined drugs, and can be used for treating arterial hypertension. The drug is prepared by direct compression. A preparation with low residual humidity is more storage stable, shows high processibility and biological availability. The combined hypotensive drug contains a combination of enalapril maleate and hydrochlorthiazide as an agent, and lactose anhydride, microcrystalline cellulose, povidone, colloidal silicon dioxide, croscarmellose sodium and stearic acid salt as excipients. The optimum proportions of the components makes, wt %: The agent 11.0-18.0; Lactose anhydride 56.0-78.0; Microcrystalline cellulose 5.0-15.0; Povidone 2.0-4.0; Colloidal silicon dioxide 0.5-1.0; Magnesium stearate 0.5-1.0; Croscarmellose sodium 3.0-5.0. ^ EFFECT: making the drug preparation for treating arterial hypertension. ^ 12 cl, 1 tbl
申请公布号 RU2444371(C1) 申请公布日期 2012.03.10
申请号 RU20100138179 申请日期 2010.09.15
申请人 OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'JU "OZON" (OOO "OZON") 发明人 TITOV VLADIMIR VJACHESLAVOVICH;ALEKSENKO PAVEL VLADIMIROVICH
分类号 A61K9/20;A61K31/549;A61K38/05;A61P9/12 主分类号 A61K9/20
代理机构 代理人
主权项
地址